Literature DB >> 11407092

Activation-induced cell death and Fas-induced apoptosis in patients with systemic or pauciarticular juvenile idiopathic arthritis.

P Pignatti1, M Massa, P Travaglino, C Meazza, A Martini, F De Benedetti.   

Abstract

OBJECTIVE: To investigate the functionality of the Fas-induced apoptotic pathway in peripheral blood mononuclear cells (PBMC) from patients with systemic or pauciarticular juvenile idiopathic arthritis (JIA).
METHODS: PBMC from 12 patients with systemic and 6 with pauciarticular JIA were activated with anti-CD3 and rhIL-2 and then incubated in the presence or absence of the anti-Fas MoAb CH11 inducing activation of the Fas apoptotic pathway. Apoptosis was evaluated by flow cytometry and fluorescence microscopy.
RESULTS: The percentage of apoptotic cells following triggering of Fas did not differ between patients with systemic JIA (12.5 +/- 9.5%) or pauciarticular JIA (18.7 +/- 8.9%) and controls (16.1 +/- 6.8%). Evaluation of activation-induced cell death (AICD) in the absence of exogenous triggering of Fas showed that 44% (8/18) of the patients with JIA, compared to none of the controls (0/16), had a percentage of apoptotic cells higher than the mean + 2 SD of controls. The increased AICD was neutralized by the addition of an anti-TNF-alpha antibody.
CONCLUSION: Patients with systemic or pauciarticular JIA do not show a defect in the Fas-dependent apoptotic pathway of T cells. The increased AICD present in some patients with JIA appears to be at least in part related to the inflammatory cytokine TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11407092

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  2 in total

1.  Ex vivo apoptosis, CD95 and CD28 expression in T cells of children with juvenile idiopathic arthritis.

Authors:  Sabine Knipp; Oliver Feyen; Jennnifer Ndagijimana; Tim Niehues
Journal:  Rheumatol Int       Date:  2002-12-04       Impact factor: 2.631

2.  A versatile system for rapid multiplex genome-edited CAR T cell generation.

Authors:  Jiangtao Ren; Xuhua Zhang; Xiaojun Liu; Chongyun Fang; Shuguang Jiang; Carl H June; Yangbing Zhao
Journal:  Oncotarget       Date:  2017-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.